Filing Details
- Accession Number:
- 0001179110-16-022919
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-08 16:03:26
- Reporting Period:
- 2016-04-07
- Filing Date:
- 2016-04-08
- Accepted Time:
- 2016-04-08 16:03:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1280600 | Acceleron Pharma Inc | XLRN | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586752 | D Steven Ertel | 128 Sidney Street Cambridge MA 02139 | Evp & Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-07 | 3,942 | $5.28 | 131,098 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-04-07 | 12,500 | $7.12 | 143,598 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-04-07 | 2,344 | $5.08 | 145,942 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-04-07 | 13,484 | $3.88 | 159,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-07 | 32,270 | $32.00 | 127,156 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2016-04-07 | 3,942 | $0.00 | 3,942 | $5.28 |
| Common Stock | Option to Purchase Common Stock | Disposition | 2016-04-07 | 12,500 | $0.00 | 12,500 | $7.12 |
| Common Stock | Option to Purchase Common Stock | Disposition | 2016-04-07 | 2,344 | $0.00 | 2,344 | $5.08 |
| Common Stock | Option to Purchase Common Stock | Disposition | 2016-04-07 | 13,484 | $0.00 | 13,484 | $3.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,365 | 2021-12-16 | No | 4 | M | Direct | |
| 12,500 | 2022-12-12 | No | 4 | M | Direct | |
| 0 | 2018-03-27 | No | 4 | M | Direct | |
| 10,209 | 2020-12-02 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The options of registrant's common stock vest in equal quarterly installments over the first four years after the grant.
Billionaire Hedge Funds
